Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Vaxart Stock Is Skyrocketing Today

TheMotleyFool

0 0

Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 21.4% higher as of 11:22 a.m. EST on Thursday. The big gains came after the drugmaker announced promising additional data from a preclinical study of its experimental oral COVID-19 vaccine.

Vaxart reported a significant reduction in lung viral loads for hamsters that received two doses of its oral vaccines and were exposed to SARS-CoV-2, the coronavirus that causes COVID-19, compared to non-vaccinated hamsters. The company previously announced results from the preclinical study that showed hamsters that received two doses of its oral vaccine candidate didn't experience systemic weight loss while unvaccinated animals lost around 9% of their total weight.

Image source: Getty Images.

Source Fool.com

Like: 0

VXRT

Share